Peace Olumese

• Ensured the Local operating company(Local OpCo) safety activities, related to medicinal and non-medicinal products were managed in compliance with local regulations and company policies/procedures at a local, regional and global levels and in accordance with any Product vigilance agreements with third party business partners
• Maintained an ongoing pro-active benefit risk management throughout product life cycle by translating global safety data to insights and actions tailoring to local specificities and needs.
• Delivered pharmacovigilance(PV) and vigilance service provisions including training, agreements / contracts containing PV Language, inspection preparation & support, and collaboration & support of other safety-related functions.
• Contributed in the design of processes & regulations procedural document including safety policy/strategy for the local operating company
• Delivered efficient and compliant safety management and reporting such as Case Processing, Translations (as required), oversight and providing Input, clinical activities compliance, submissions to Regulatory Authorities, signal detection, aggregate reporting, literature search, business continuity, risk management and new safety Information.
• Established an appropriate Pharmaco- and consumer product vigilance and Risk management systems in place in order to assure appropriate oversight for products within its responsibility
• Acted as the Local Nominated Person for Pharmacovigilance assuming the PV role as defined by national law while collaborating with the EU-QPPV offices as required.

Key Achievements

• Actively participated in the global Covid-19 vaccine Local Medical Safety team to deliver medical safety knowledge training to the international pharmacovigilance organization and currently involved in ongoing updates on safety knowledge for the vaccine.
• Actively involved in the Europe,Middle East and Africa(EMEA) regional Covid-19 vaccine network team in providing support to individual countries for successful implementation of the emergency use launch of the Covid-19 vaccine.
• Actively contributed as a key member within the training and education LMS labs towards the successful implementation in EMEA and led an Empowered Community Network(ECN) subgroup to collaborate with IPV affairs on project management needs of the IPV community while actively supporting and demonstrated diversity and inclusion.
• Proactively championed the Local Medical Safety within the SSA region by driving innovative collaborations within the local operating company with internal stakeholders (i.e. Commercial, Medical Affairs etc.) to deliver safety focused presentations and discussions to external stakeholders(i.e. healthcare professionals) in the Oncology and Neuroscience space using regionally developed tools such as the LMS Risk Management Plan template while sharing best practices with colleagues within the SSA region.
• Successfully rolled out multiple innovative and locally tailored pharmacovigilance (PV) initiatives within the Local OpCo such the NIGERIA DRUG-SAFE PV initiative, Adverse Event Memory Aide, On-demand PV and product safety trainings etc. resulting in improved safety surveillance and an increase versus the previous year in both the quantity(over 300%) and quality of adverse events reported
• Succeeded in implementing the local medical safety strategy within the Nigeria Local OpCo with specific focus on priority products such as the enhanced DRUG-SAFE campaign with safety messages in Psychiatry, shaping regulations with NAFDAC and drove strategic high-value collaborations with key-stakeholders for Pharma and Consumer such as first ever virtual visit via Digital platforms for oncology and neuroscience while driving high standard of compliance for safety-related activities in the Local OpCo.

• Ensured the Local operating company safety activities, related to medicinal and non-medicinal products were managed in compliance with local regulations and company policies/procedures at a local, regional and global levels and in accordance with any Product vigilance agreements with third party business partners
• Delivered pharmacovigilance(PV) and vigilance service provisions including training, agreements / contracts containing PV Language, inspection preparation & support, and collaboration & support of other safety-related functions.
• Contributed in the design of processes & regulations procedural document including safety policy/strategy for the local operating company
• Delivered efficient and compliant safety management and reporting such as Case Processing, Translations (as required), oversight and providing Input, clinical activities compliance, submissions to Regulatory Authorities, signal detection, aggregate reporting, literature search, business continuity, risk management and new safety Information.
• Established an appropriate Pharmaco- and consumer product vigilance and Risk management systems in place in order to assure appropriate oversight for products within its responsibility
• Acted as the Local Nominated Person for Pharmacovigilance assuming the PV role as defined by national law while collaborating with the EU-QPPV offices as required.

Key Achievements

• Pro-actively developed a working relationship with the local health authority, NAFDAC and successfully established contact with the PV and Clinical Trails departments while also holding key discussions separately with stakeholders within the specific units helping to ensure a more collaborative working relationship in the near future
• Supported the local safety unit(LSU) Nigeria in ensuring high quality safety reporting by employees, business partners and contractors of the LOC which was achieved by engaging physically with any of such persons involved at any time in any of the processes of safety reporting and following up closely to ensure that timely and complaint responses are sent in to LSU as well as the Health Authorities.

• Generated revenue by liaising between doctors and companies to sell products.
• Developed sales forecasts in collaboration with Regional Sales manager to estimate future revenue.
• Facilitated upselling by cultivating productive relationships with clients, including staff at doctor offices, clinics and surgical centers.
• Documented client interactions, sales and pitches delivered in CRM system.
• Worked with medical teams on smooth implementation and operation of new products.
• Supplied hospitals and physicians with in-depth information on Concor (Bisoprolol), Glucovance and Glucophage.
• Worked alongside retail representatives to boost sales by enhancing product presentations.

Key Achievements

• Successfully launched Merck’s new cardiovascular line, Concor (Bisoprolol) at the Nigerian Cardiac Society Conference 2017.
• Ensured the enlisting of the Merck’s newly launched Brand Concor in the public tender of some key of our Institutions such as the University of Benin Teaching Hospital and NNPC Warri Medical Division
• Penetrated new territories, successfully establishing relationships with over 15 accounts within 1 year.

• Generated revenue by liaising between doctors and companies to sell products.
• Developed sales forecasts in collaboration with Regional sales to estimate future revenue.
• Grew account base over 50% by delivering high-impact product presentations to medical specialists.
• Worked with medical teams on smooth implementation and operation of new products.
• Documented client interactions, sales and pitches delivered in CRM system.
• Supplied hospitals and physicians with in-depth information on Symbicort, Pulmicort and Nexium.
• Worked alongside retail representatives to boost sales by enhancing product presentations.

Key Achievements

• Achieved a 200% growth from previous year on my first line brand while effectively developing the business growth.
• Successfully launched the Africa breathe project in Edo and Delta state with up 15 hospitals benefiting from the nebulization projects
• Successfully enlisted a focus brand Pulmicort into drug formulary of my major institutions, University of Benin teaching hospital.

• Managed clinical pharmacy activities including prescription assessment, dispensing, stock management, drug procurement and drug use monitoring.
• Managed the drug unit of the anti-retroviral and anti-tuberculosis clinic in collaboration with the non-profit organization, FHI360 in delivering pharmacotherapy for HIV and tuberculosis patients.
• Actively contributed as a functioning member of the anti-retroviral therapy review committee in detailed assessment and handling of individual cases of drug treatment failure and drug resistance.

Key Achievements

• Successfully ensured a seamless delivery of anti-retroviral and anti-tuberculosis drugs therapy to HIV and tuberculosis patients on their clinic days
• Delivered timely reports to the sponsors(FHI 360) on registered clients and consumption rates including stock outs and expiries.
• Successfully provided standard counseling for all treatment naive HIV patients prior to initiation of anti-HIV medications.

• Compared prescription details against safety standards and insurance requirements to support patients.
• Educated patients on possible drug interactions, potential side effects and optimal methods of administration.
• Counseled patients on new medications and OTC products.
• Assisting the hospital pharmacists in managing clinical pharmacy activities including prescription assessment, dispensing, stock management, drug procurement and drug monitoring
• Prepared packaging and labels for prescriptions, verifying accuracy of dosage, side effects, interactions and refill instructions.

Key Achievements

• Assisted in ensuring patient prescriptions were dispensed timely and error free and actively advocated for patient safety with other health care providers.
• Constantly interacted with team members in the hospital in the delivering of multi-disciplinary care to ensure optimal patient care delivery.
• Effectively managed the pharmacy technicians to reduce patient waiting time.